“I was pondering how 390 patients many serious c
Post# of 148187
The PR state/s that Novant is enrolling patients in the mild to moderate phase 2 and does not mention enrollment of patients into the severe patient, phase 2b/3 trial.
“Novant Heath is initiating patient enrollment in CytoDyn’s Phase 2 randomized clinical trial for COVID-19 patients with mild-to-moderate indications.”
I’d hate to assume, but I’m assuming they can enroll patients in the severe trial as well, which would help speed up enrollment.